Mutation Screening of ATXN1, ATXN2, and ATXN3 in Amyotrophic Lateral Sclerosis
- 4 November 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- p. 1-12
Abstract
Emerging evidence suggests potential disease modifying roles of ATXN1, ATXN2, and ATXN3 in amyotrophic lateral sclerosis (ALS). We aimed to provide a comprehensive variants profile of the ATXN1, ATXN2, and ATXN3 genes and examine the association of these variants with the risk and clinical characteristics of ALS. We screened and analyzed the rare variants in a cohort of 2220 ALS patients from Southwest China, using controls from the Genome Aggregation Database (gnomAD) and the China Metabolic Analytics Project (ChinaMAP). The over-representation of rare variants and their association with disease risk in ALS patients were assessed using Fisher’s exact test with Bonferroni correction at both allele and gene levels. Kaplan–Meier analysis was employed to explore the relationship between the distribution of variants and survival. A total of 62 eligible rare missense variants were identified, comprising 32 from ATXN1, 21 from ATXN2, and 9 from ATXN3. Allelic association testing revealed a significant enrichment of the ATXN1 (c.2122C > G, p.Leu708Val) variant and the ATXN2 (c.3778C > G, p.Pro1260Ala) variant in ALS. Gene burden analysis indicated that variants in the ATXN1 and ATXN3 genes had a higher burden in ALS. Substantial heterogeneity in survival time was observed among patients carrying different variants within the same gene. However, there were no significant differences in survival between ALS patients grouped by N-terminal or C-terminal distribution. Our results provided a genetic variation profile of ATXN1, ATXN2, and ATXN3 in ALS patients, along with the clinical characteristics of individuals carrying these variations. This information might offer valuable insights for the ongoing ALS disease-modifying treatments.Keywords
Funding Information
- National Natural Science Foundation of China (82371430)
- Sichuan Science and Technology Program (2022ZDZX0023)
This publication has 41 references indexed in Scilit:
- Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosisNeurobiology of Disease, 2022
- Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotypeNeurological Sciences, 2022
- Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in AfricansIBRO Neuroscience Reports, 2021
- Shared genetic links between amyotrophic lateral sclerosis and obesity-related traits: a genome-wide association studyNeurobiology of Aging, 2021
- CAG repeats ≥ 34 in Ataxin-1 gene are associated with amyotrophic lateral sclerosis in a Brazilian cohortJournal of the Neurological Sciences, 2020
- ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosisNeurobiology of Aging, 2018
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Amyotrophic Lateral Sclerosis Risk for Spinocerebellar Ataxia Type 2ATXN2CAG Repeat AllelesJAMA Neurology, 2014
- The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effectNeurobiology of Disease, 2012
- Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosisNeurobiology of Aging, 2011